Avaliação das atividades citotóxicas e imunomoduladora de paládio(II) contendo o ligante DMBA= N,N-dimetilbenzilamina
Autor(a) principal: | |
---|---|
Data de Publicação: | 2014 |
Tipo de documento: | Dissertação |
Idioma: | por |
Título da fonte: | Repositório Institucional da UNESP |
Texto Completo: | http://hdl.handle.net/11449/121925 |
Resumo: | The cancer manifestation caused by uncontrolled growth of cells, affects millions of individuals and is a major cause of death worldwide. Considering that the drugs currently available for the treatment of limited efficacy (such as cisplatin) commonly linked to high toxicity, the search for new compounds capable of fighting cancer cells is urgently needed. With this growing interest in investigating new substances that are not toxic, but selective. Compounds of palladium(II) have been studied as an alternative to available drugs showing be promising for its low toxicity and ability to stimulate antitumor immune response. Macrophages are the first cells to be activated to participate in an immune response itself and cells are able to secrete more than hundred biologically active products, among these, reactive nitrogen species and active cytokines in the immune response and tissue formation. In this work seven compounds of palladium(II) were tested for potential antitumor and immune being: [Pd(dmba) (μ-Cl)]2 (1), [Pd(dma)(μ-N3)]2•H2O (2), [Pd (dmba)(μ-NCO)]2 (3), [Pd(dmba)Cl(isn)] (4), [Pd(dmba)(N3)(isn)] (5), [Pd(dmba)(NCO)(isn)] (6) {DMBA = N, Ndimethylbenzylamine; ISN = -isonicotinamide; Cl = chloro; N3 = azide; and NCO = cyanate}; and [Pd(C-dmba)(NCS)(dppp)] (7) = {DMBA = N,N‟ – dimethylbenzylamine; NCS= thiocyanate and DPPP = difenilfosfinapropano}. The compounds were tested by colorimetric assay of MTT, 3 [4,5-dimethylthiazol-2-yl] -2,5-diphenyl-tetrazolium. Compounds that showed better results (3.4 and 7, compared with cisplatin) were subjected to the MTT assay in order to trace their cytostatic and cytotoxic profile against LM3 cell line (murine mammary carcinoma), and analysis of apoptosis Flow Cytometry results involving cytotoxicity on these two cell types showed that each compound acts differently. Featured, against LM3 lineage compound 3 showed efficacy at a concentration of 25 mg / mL, as compound 4 showed the best ... |
id |
UNSP_c412b045da6959edc68bf966e76e0531 |
---|---|
oai_identifier_str |
oai:repositorio.unesp.br:11449/121925 |
network_acronym_str |
UNSP |
network_name_str |
Repositório Institucional da UNESP |
repository_id_str |
2946 |
spelling |
Avaliação das atividades citotóxicas e imunomoduladora de paládio(II) contendo o ligante DMBA= N,N-dimetilbenzilaminaPaládioMamas - CancerMacrofagosCitotoxicidadeCytotoxicityThe cancer manifestation caused by uncontrolled growth of cells, affects millions of individuals and is a major cause of death worldwide. Considering that the drugs currently available for the treatment of limited efficacy (such as cisplatin) commonly linked to high toxicity, the search for new compounds capable of fighting cancer cells is urgently needed. With this growing interest in investigating new substances that are not toxic, but selective. Compounds of palladium(II) have been studied as an alternative to available drugs showing be promising for its low toxicity and ability to stimulate antitumor immune response. Macrophages are the first cells to be activated to participate in an immune response itself and cells are able to secrete more than hundred biologically active products, among these, reactive nitrogen species and active cytokines in the immune response and tissue formation. In this work seven compounds of palladium(II) were tested for potential antitumor and immune being: [Pd(dmba) (μ-Cl)]2 (1), [Pd(dma)(μ-N3)]2•H2O (2), [Pd (dmba)(μ-NCO)]2 (3), [Pd(dmba)Cl(isn)] (4), [Pd(dmba)(N3)(isn)] (5), [Pd(dmba)(NCO)(isn)] (6) {DMBA = N, Ndimethylbenzylamine; ISN = -isonicotinamide; Cl = chloro; N3 = azide; and NCO = cyanate}; and [Pd(C-dmba)(NCS)(dppp)] (7) = {DMBA = N,N‟ – dimethylbenzylamine; NCS= thiocyanate and DPPP = difenilfosfinapropano}. The compounds were tested by colorimetric assay of MTT, 3 [4,5-dimethylthiazol-2-yl] -2,5-diphenyl-tetrazolium. Compounds that showed better results (3.4 and 7, compared with cisplatin) were subjected to the MTT assay in order to trace their cytostatic and cytotoxic profile against LM3 cell line (murine mammary carcinoma), and analysis of apoptosis Flow Cytometry results involving cytotoxicity on these two cell types showed that each compound acts differently. Featured, against LM3 lineage compound 3 showed efficacy at a concentration of 25 mg / mL, as compound 4 showed the best ...O câncer, manifestação originada pelo crescimento descontrolado de células, afeta milhões de indivíduos e é uma das principais causas de morte em todo mundo. Tendo em vista que os fármacos atualmente disponíveis para o tratamento apresentam eficácia limitada (como a cisplatina) comumente atrelada à alta toxicidade, a busca por novos compostos capazes de combater células cancerígenas é uma necessidade premente. Com isso, cresce o interesse de se investigar novas substâncias que não sejam tóxicas, mas sim seletivas. Os compostos de paládio(II) têm sido estudados como uma alternativa aos fármacos disponíveis, mostrando-se promissores por sua menor toxicidade e capacidade de estimular a resposta imune antitumoral. Os macrófagos são as primeiras células a serem ativadas para participar de uma resposta imunológica propriamente dita e são células capazes de secretar mais de cem produtos biologicamente ativos, entre esses, espécies reativas de nitrogênio e citocinas atuantes na resposta imunológica e na formação tecidual. Neste trabalho foram testados sete compostos de paládio(II) quanto ao potencial imunológico e antitumoral, sendo eles: [Pd(dmba)(μ-Cl)]2 (1), [Pd(dmba)(μ-N3)]2•H2O (2), [Pd(dmba)(μ-NCO)]2 (3), [Pd(dmba)Cl(isn)] (4), [Pd(dmba)(N3)(isn)] (5), [Pd(dmba)(NCO)(isn)] (6) {DMBA= N,Ndimetilbenzilamina; ISN= isonicotinamida; Cl= cloro; N3= azida; e NCO= cianato}; e [Pd(Cdmba)( NCS)(dppp)] (7) {DMBA = N,N-dimetilbenzilamina; NCS = tiocianato e DPPP = difenilfosfinapropano}. Os compostos foram testados quanto pelo teste colorimétrico de MTT, brometo de 3-[4,5-dimetiltiazol-2-il]-2,5-difenil-tetrazólio. Os compostos que apresentaram melhores resultados (3,4 e 7, em comparação com a cisplatina), foram submetidos ao teste do MTT a fim de traçar seu perfil citotóxico e citostático frente a linhagem celular LM3 (carcinoma mamário murino), além de quantificar citocinas e analisar a apoptose por Citometria ...Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)Universidade Estadual Paulista (Unesp)Carlos, Iracilda Zeppone [UNESP]Universidade Estadual Paulista (Unesp)Jardim, Mauro Guilherme Dall’Acqua [UNESP]2015-04-09T12:28:11Z2015-04-09T12:28:11Z2014-11-28info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisxiii, 82 f. : figs.application/pdfJARDIM, Mauro Guilherme Dall’Acqua. Avaliação das atividades citotóxicas e imunomoduladora de paládio(II) contendo o ligante DMBA= N,N-dimetilbenzilamina. 2014. xiii, 82 f. Dissertação (mestrado) - Universidade Estadual Paulista, Faculdade de Ciências Farmacêuticas, 2014.http://hdl.handle.net/11449/121925000815527000815527.pdf33004030081P71730146818754269Alephreponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPporinfo:eu-repo/semantics/openAccess2024-06-24T18:10:09Zoai:repositorio.unesp.br:11449/121925Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestopendoar:29462024-08-05T23:08:30.675116Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false |
dc.title.none.fl_str_mv |
Avaliação das atividades citotóxicas e imunomoduladora de paládio(II) contendo o ligante DMBA= N,N-dimetilbenzilamina |
title |
Avaliação das atividades citotóxicas e imunomoduladora de paládio(II) contendo o ligante DMBA= N,N-dimetilbenzilamina |
spellingShingle |
Avaliação das atividades citotóxicas e imunomoduladora de paládio(II) contendo o ligante DMBA= N,N-dimetilbenzilamina Jardim, Mauro Guilherme Dall’Acqua [UNESP] Paládio Mamas - Cancer Macrofagos Citotoxicidade Cytotoxicity |
title_short |
Avaliação das atividades citotóxicas e imunomoduladora de paládio(II) contendo o ligante DMBA= N,N-dimetilbenzilamina |
title_full |
Avaliação das atividades citotóxicas e imunomoduladora de paládio(II) contendo o ligante DMBA= N,N-dimetilbenzilamina |
title_fullStr |
Avaliação das atividades citotóxicas e imunomoduladora de paládio(II) contendo o ligante DMBA= N,N-dimetilbenzilamina |
title_full_unstemmed |
Avaliação das atividades citotóxicas e imunomoduladora de paládio(II) contendo o ligante DMBA= N,N-dimetilbenzilamina |
title_sort |
Avaliação das atividades citotóxicas e imunomoduladora de paládio(II) contendo o ligante DMBA= N,N-dimetilbenzilamina |
author |
Jardim, Mauro Guilherme Dall’Acqua [UNESP] |
author_facet |
Jardim, Mauro Guilherme Dall’Acqua [UNESP] |
author_role |
author |
dc.contributor.none.fl_str_mv |
Carlos, Iracilda Zeppone [UNESP] Universidade Estadual Paulista (Unesp) |
dc.contributor.author.fl_str_mv |
Jardim, Mauro Guilherme Dall’Acqua [UNESP] |
dc.subject.por.fl_str_mv |
Paládio Mamas - Cancer Macrofagos Citotoxicidade Cytotoxicity |
topic |
Paládio Mamas - Cancer Macrofagos Citotoxicidade Cytotoxicity |
description |
The cancer manifestation caused by uncontrolled growth of cells, affects millions of individuals and is a major cause of death worldwide. Considering that the drugs currently available for the treatment of limited efficacy (such as cisplatin) commonly linked to high toxicity, the search for new compounds capable of fighting cancer cells is urgently needed. With this growing interest in investigating new substances that are not toxic, but selective. Compounds of palladium(II) have been studied as an alternative to available drugs showing be promising for its low toxicity and ability to stimulate antitumor immune response. Macrophages are the first cells to be activated to participate in an immune response itself and cells are able to secrete more than hundred biologically active products, among these, reactive nitrogen species and active cytokines in the immune response and tissue formation. In this work seven compounds of palladium(II) were tested for potential antitumor and immune being: [Pd(dmba) (μ-Cl)]2 (1), [Pd(dma)(μ-N3)]2•H2O (2), [Pd (dmba)(μ-NCO)]2 (3), [Pd(dmba)Cl(isn)] (4), [Pd(dmba)(N3)(isn)] (5), [Pd(dmba)(NCO)(isn)] (6) {DMBA = N, Ndimethylbenzylamine; ISN = -isonicotinamide; Cl = chloro; N3 = azide; and NCO = cyanate}; and [Pd(C-dmba)(NCS)(dppp)] (7) = {DMBA = N,N‟ – dimethylbenzylamine; NCS= thiocyanate and DPPP = difenilfosfinapropano}. The compounds were tested by colorimetric assay of MTT, 3 [4,5-dimethylthiazol-2-yl] -2,5-diphenyl-tetrazolium. Compounds that showed better results (3.4 and 7, compared with cisplatin) were subjected to the MTT assay in order to trace their cytostatic and cytotoxic profile against LM3 cell line (murine mammary carcinoma), and analysis of apoptosis Flow Cytometry results involving cytotoxicity on these two cell types showed that each compound acts differently. Featured, against LM3 lineage compound 3 showed efficacy at a concentration of 25 mg / mL, as compound 4 showed the best ... |
publishDate |
2014 |
dc.date.none.fl_str_mv |
2014-11-28 2015-04-09T12:28:11Z 2015-04-09T12:28:11Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/masterThesis |
format |
masterThesis |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
JARDIM, Mauro Guilherme Dall’Acqua. Avaliação das atividades citotóxicas e imunomoduladora de paládio(II) contendo o ligante DMBA= N,N-dimetilbenzilamina. 2014. xiii, 82 f. Dissertação (mestrado) - Universidade Estadual Paulista, Faculdade de Ciências Farmacêuticas, 2014. http://hdl.handle.net/11449/121925 000815527 000815527.pdf 33004030081P7 1730146818754269 |
identifier_str_mv |
JARDIM, Mauro Guilherme Dall’Acqua. Avaliação das atividades citotóxicas e imunomoduladora de paládio(II) contendo o ligante DMBA= N,N-dimetilbenzilamina. 2014. xiii, 82 f. Dissertação (mestrado) - Universidade Estadual Paulista, Faculdade de Ciências Farmacêuticas, 2014. 000815527 000815527.pdf 33004030081P7 1730146818754269 |
url |
http://hdl.handle.net/11449/121925 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
xiii, 82 f. : figs. application/pdf |
dc.publisher.none.fl_str_mv |
Universidade Estadual Paulista (Unesp) |
publisher.none.fl_str_mv |
Universidade Estadual Paulista (Unesp) |
dc.source.none.fl_str_mv |
Aleph reponame:Repositório Institucional da UNESP instname:Universidade Estadual Paulista (UNESP) instacron:UNESP |
instname_str |
Universidade Estadual Paulista (UNESP) |
instacron_str |
UNESP |
institution |
UNESP |
reponame_str |
Repositório Institucional da UNESP |
collection |
Repositório Institucional da UNESP |
repository.name.fl_str_mv |
Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP) |
repository.mail.fl_str_mv |
|
_version_ |
1808129494121185280 |